Literature DB >> 18230718

IP6K2 is a client for HSP90 and a target for cancer therapeutics development.

David S Shames1, John D Minna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18230718      PMCID： PMC2234151          DOI： 10.1073/pnas.0711993105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  16 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

3.  HSP90 regulates cell survival via inositol hexakisphosphate kinase-2.

Authors:  Anutosh Chakraborty; Michael A Koldobskiy; Katherine M Sixt; Krishna R Juluri; Asif K Mustafa; Adele M Snowman; Damian B van Rossum; Randen L Patterson; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-14       Impact factor: 11.205

Review 4.  Heat-shock protein 90, a chaperone for folding and regulation.

Authors:  D Picard
Journal:  Cell Mol Life Sci       Date:  2002-10       Impact factor: 9.261

5.  Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells.

Authors:  B H Morrison; J A Bauer; D V Kalvakolanu; D J Lindner
Journal:  J Biol Chem       Date:  2001-05-03       Impact factor: 5.157

6.  Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function.

Authors:  Andrea D Basso; David B Solit; Gabriela Chiosis; Banabihari Giri; Philip Tsichlis; Neal Rosen
Journal:  J Biol Chem       Date:  2002-08-09       Impact factor: 5.157

7.  A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors.

Authors:  Adeela Kamal; Lia Thao; John Sensintaffar; Lin Zhang; Marcus F Boehm; Lawrence C Fritz; Francis J Burrows
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

Review 8.  Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers.

Authors:  Eugene R Zabarovsky; Michael I Lerman; John D Minna
Journal:  Oncogene       Date:  2002-10-07       Impact factor: 9.867

Review 9.  Targeting multiple signal transduction pathways through inhibition of Hsp90.

Authors:  Hong Zhang; Francis Burrows
Journal:  J Mol Med (Berl)       Date:  2004-05-27       Impact factor: 4.599

Review 10.  Dynamic remodeling of transcription complexes by molecular chaperones.

Authors:  Richard I Morimoto
Journal:  Cell       Date:  2002-08-09       Impact factor: 66.850
View more
  13 in total

Review 1.  Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs.

Authors:  Xiangyi Lu; Li Xiao; Luan Wang; Douglas M Ruden
Journal:  Biochem Pharmacol       Date:  2011-11-22       Impact factor: 5.858

Review 2.  Interferons as inducers of apoptosis in malignant cells.

Authors:  Kevin P Kotredes; Ana M Gamero
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

3.  Mechanistic studies of Sansalvamide A-amide: an allosteric modulator of Hsp90.

Authors:  Robert C Vasko; Rodrigo A Rodriguez; Christian N Cunningham; Veronica C Ardi; David A Agard; Shelli R McAlpine
Journal:  ACS Med Chem Lett       Date:  2010-01-01       Impact factor: 4.345

Review 4.  The inositol pyrophosphate pathway in health and diseases.

Authors:  Anutosh Chakraborty
Journal:  Biol Rev Camb Philos Soc       Date:  2017-12-27

5.  The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatin.

Authors:  Veronika Kvardova; Roman Hrstka; Dawid Walerych; Petr Muller; Eva Matoulkova; Veronika Hruskova; Dagmar Stelclova; Petr Sova; Borivoj Vojtesek
Journal:  Mol Cancer       Date:  2010-06-15       Impact factor: 27.401

6.  Synthesis and SAR study of N-(4-hydroxy-3-(2-hydroxynaphthalene-1-yl)phenyl)-arylsulfonamides: heat shock protein 90 (Hsp90) inhibitors with submicromolar activity in an in vitro assay.

Authors:  Thota Ganesh; Pahk Thepchatri; Lian Li; Yuhong Du; Haian Fu; James P Snyder; Aiming Sun
Journal:  Bioorg Med Chem Lett       Date:  2008-08-14       Impact factor: 2.823

7.  Interaction of cepharanthine with immobilized heat shock protein 90α (Hsp90α) and screening of Hsp90α inhibitors.

Authors:  Jun Haginaka; Tomoko Kitabatake; Iyo Hirose; Hisami Matsunaga; Ruin Moaddel
Journal:  Anal Biochem       Date:  2012-12-03       Impact factor: 3.365

Review 8.  Cancer and virus leads by HTS, chemical design and SEA data mining.

Authors:  Pahk Thepchatri; Jaeki Min; Thota Ganesh; Yuhong Du; Iestyn Lewis; Serdar Kurtkaya; Andrew Prussia; Lian Li; Blossom Sneed; Richard K Plemper; Haian Fu; Dennis C Liotta; James P Snyder; Raymond Dingledine; Aiming Sun
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

Review 9.  Obesity and cancer risk: evidence, mechanisms, and recommendations.

Authors:  Ivana Vucenik; Joseph P Stains
Journal:  Ann N Y Acad Sci       Date:  2012-10       Impact factor: 5.691

10.  Human calmodulin methyltransferase: expression, activity on calmodulin, and Hsp90 dependence.

Authors:  Sophia Magen; Roberta Magnani; Sitvanit Haziza; Eli Hershkovitz; Robert Houtz; Franca Cambi; Ruti Parvari
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.